Full Press Release Details
AI to Discuss Findings from its Collaboration with Lieber Institute for Brain Development in Fireside Chat Hosted by RedChip
MD - February 9, 2024 - BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"),
a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development
of pharmaceuticals and biologics, today announced its CEO, Vin Singh, alongside distinguished guest, Daniel R. Weinberger, M.D., Director
and CEO of the Lieber Institute for Brain Development (LIBD), will participate in a fireside chat hosted by RedChip Companies on March
5, 2024 at 4:15 p.m. ET.
fireside chat will delve into the early findings from BullFrog AI and LIBD's collaboration which successfully stratified brain
expression data, offering what may turn out to be unprecedented insights into psychiatric conditions.
collaborative effort marks a pivotal moment in psychiatric research, utilizing over 2,800 brain samples to explore schizophrenia, bipolar
disorder, major depressive disorder, and control groups through advanced graph analytics. For the first time, this partnership has enabled
the clustering of subjects based on biological data alone, independent of their behavioral diagnoses. This innovative method has uncovered
biological differences and similarities across various brain disorders and has identified potential biological subtypes within individual
disorders. These findings have the potential to not only enhance our understanding of psychiatric conditions but also lay the groundwork
for developing more targeted, effective treatments and open the door to prospective revenue-generating partnerships with pharmaceutical
participate in the fireside chat, please register at:
fireside chat will include a live Q&A session. Questions can also be pre-submitted to rob@redchip.com.
the Lieber Institute for Brain Development (LIBD)
mission of the Lieber Institute for Brain Development and the Maltz Research Laboratories is to translate the understanding of
basic genetic and molecular mechanisms of schizophrenia and related developmental brain disorders into clinical advances that change
the lives of affected individuals. LIBD is an independent, not-for-profit 501(c)(3) organization and a Maryland tax-exempt medical research
institute. The Lieber Institute's brain repository of more than 4,000 human brains is the largest collection of postmortem brains
for the study of neuropsychiatric disorders in the world.
AI is a technology-enabled drug development company using Artificial Intelligence and machine learning to enable the successful development
of pharmaceuticals and biologics. Through its collaborations with leading research institutions, BullFrog AI is at the forefront of AI-driven
drug development using its proprietary bfLEAP artificial intelligence platform to create and analyze networks of biological, clinical,
and real-world data spanning from early discovery to late-stage clinical trials. BullFrog AI is deploying bfLEAP for use at several
critical stages of development with the intention of streamlining data analytics in therapeutics development, decreasing the overall
development costs by decreasing failure rates for new therapeutics.
more information visit BullFrog AI at:
press release contains forward-looking statements. We base these forward-looking statements on our expectations and projections about
future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events
or our future performance, including: our financial performance and projections; our growth in revenue and earnings; and our business
prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those
that use terminology such as "may," "should," "expects," "anticipates," "contemplates,"
"estimates," "believes," "plans," "projected," "predicts," "potential,"
or "hopes" or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider
various factors, including: our ability to change the direction of the Company; our ability to keep pace with new technology and changing
market needs; and the competitive environment of our business. These and other factors may cause our actual results to differ materially
from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this press
release and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ
materially and are subject to risks, uncertainties, and assumptions about us. We are not obligated to publicly update or revise any forward-looking
statement, whether as a result of uncertainties and assumptions, the forward-looking events discussed in this press release and other
statements made from time to time by us or our representatives might not occur.
RedChip Companies, Inc.
BullFrog AI Holdings, Inc.